F. Cardenal
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 21
- Lung Cancer Diagnosis and Treatment 15
- Oncology 18
- Lung Cancer Research Studies 13
- Colorectal Cancer Treatments and Studies 4
- Peptidase Inhibition and Analysis 2
- Co-authors
- Carlos Camps (4 shared papers)Rafael Rosell (3 shared papers)Miquel Tarón (6 shared papers)José Javier Sánchez (2 shared papers)Manuel Dómine (6 shared papers)Vicente Alberola (2 shared papers)Jan Brabender (1 shared paper)José Miguel Sánchez (1 shared paper)
- Journals
- Journal of Clinical Oncology (13 papers)European Journal of Cancer (5 papers)Lung Cancer (4 papers)European Urology (1 paper)European Journal of Cancer Supplements (2 papers)
- Partner nations
- SpainGermanyUnited States
In The Last Decade
F. Cardenal
25 papers receiving 916 citations
F. Cardenal's Hit Papers
Peers
Comparison fields: 5 of 53
- Oncology 585
- Pulmonary and Respiratory Medicine 632
- Cancer Research 202
- Molecular Biology 416
- Pathology and Forensic Medicine 96
Countries citing papers authored by F. Cardenal
This map shows the geographic impact of F. Cardenal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Cardenal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Cardenal more than expected).
Fields of papers citing papers by F. Cardenal
This network shows the impact of papers produced by F. Cardenal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Cardenal. The network helps show where F. Cardenal may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Cardenal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. Hit paper breakdown → | 2002 | 551 |
| 2 | 2003 | 148 | |
| 3 | 2011 | 110 | |
| 4 | 2008 | 38 | |
| 5 | 2015 | 24 | |
| 6 | 2009 | 11 | |
| 7 | 2010 | 11 | |
| 8 | 2008 | 8 | |
| 9 | 2007 | 6 | |
| 10 | 1993 | 5 | |
| 11 | 2011 | 5 | |
| 12 | 2009 | 5 | |
| 13 | 2005 | 4 | |
| 14 | 1999 | 4 | |
| 15 | 1997 | 3 | |
| 16 | 1999 | 3 | |
| 17 | 2003 | 2 | |
| 18 | 2007 | 1 | |
| 19 | 2017 | 1 | |
| 20 | 2008 | 1 |
About F. Cardenal
F. Cardenal is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Cancer Research, having authored 26 papers that have together received 946 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (21 papers), Lung Cancer Diagnosis and Treatment (15 papers), Lung Cancer Research Studies (13 papers), Colorectal Cancer Treatments and Studies (4 papers), Radiomics and Machine Learning in Medical Imaging (4 papers), Cancer Genomics and Diagnostics (3 papers), Cancer therapeutics and mechanisms (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Oncology (585 citations), Pulmonary and Respiratory Medicine (632 citations), Cancer Research (202 citations), Molecular Biology (416 citations) and Pathology and Forensic Medicine (96 citations). F. Cardenal has collaborated with scholars based in Spain, Germany and United States. Frequent co-authors include Carlos Camps, Rafael Rosell, Miquel Tarón, José Javier Sánchez, Manuel Dómine, Vicente Alberola, Jan Brabender, José Miguel Sánchez, Paul H. Gumerlock and Kathleen D. Danenberg. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Lung Cancer, European Urology and European Journal of Cancer Supplements.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.